| First Author | Arefieva AB | Year | 2023 |
| Journal | Biomolecules | Volume | 13 |
| Issue | 10 | PubMed ID | 37892138 |
| Mgi Jnum | J:342914 | Mgi Id | MGI:7545838 |
| Doi | 10.3390/biom13101458 | Citation | Arefieva AB, et al. (2023) In Vitro and In Vivo Chaperone Effect of (R)-2-amino-6-(1R, 2S)-1,2-dihydroxypropyl)-5,6,7,8-tetrahydropterin-4(3H)-one on the C1473G Mutant Tryptophan Hydroxylase 2. Biomolecules 13(10) |
| abstractText | Tryptophan hydroxylase 2 (TPH2) is the key and rate-limiting enzyme of serotonin (5-HT) synthesis in the mammalian brain. The 1473G mutation in the Tph2 gene decreases TPH2 activity in the mouse brain by twofold. (R)-2-amino-6-(1R, 2S)-1,2-dihydroxypropyl)-5,6,7,8-tetrahydropterin-4(3H)-one (BH(4)) is a pharmacological chaperone for aromatic amino acid hydroxylases. In the present study, chaperone effects of BH(4) on the mutant C1473G TPH2 were investigated in vitro and in vivo. In vitro BH(4) increased the thermal stability (T(50) value) of mutant and wild-type TPH2 molecules. At the same time, neither chronic (twice per day for 7 days) intraperitoneal injection of 48.3 mg/kg of BH(4) nor a single intraventricular administration of 60 mug of the drug altered the mutant TPH2 activity in the brain of Balb/c mice. This result indicates that although BH(4) shows a chaperone effect in vitro, it is unable to increase the activity of mutant TPH2 in vivo. |
